Birdwatch Note
2024-08-01 15:43:24 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The statement conflates concepts: Hyperandrogenism involves high androgen levels, not XY chromosomes. XY typically indicates male genetics, some intersex conditions (e.g., Androgen Insensitivity Syndrome) present female traits. https://rarediseases.info.nih.gov/diseases/5635/androgen-insensitivity-syndrome https://www.healthline.com/health/hyperandrogenism
Written by C1B33C87FC930AC1E491F3ECAEC3BBB37DAC6FAB4505D6DA2FE39F5D9E4F5149
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1819030524045754452
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1819036216001441810
- noteId - 1819036216001441810
- participantId -
- noteAuthorParticipantId - C1B33C87FC930AC1E491F3ECAEC3BBB37DAC6FAB4505D6DA2FE39F5D9E4F5149 Participant Details
- createdAtMillis - 1722527004608
- tweetId - 1819030524045754452
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The statement conflates concepts: Hyperandrogenism involves high androgen levels, not XY chromosomes. XY typically indicates male genetics, some intersex conditions (e.g., Androgen Insensitivity Syndrome) present female traits. https://rarediseases.info.nih.gov/diseases/5635/androgen-insensitivity-syndrome https://www.healthline.com/health/hyperandrogenism
Note Ratings
rated at | rated by | |
2024-08-02 14:27:37 -0500 | Rating Details | |
2024-08-02 13:03:30 -0500 | Rating Details | |
2024-08-02 09:14:34 -0500 | Rating Details | |
2024-08-02 08:47:07 -0500 | Rating Details | |
2024-08-02 07:13:28 -0500 | Rating Details | |
2024-08-02 06:29:45 -0500 | Rating Details | |
2024-08-02 06:09:31 -0500 | Rating Details | |
2024-08-02 05:04:16 -0500 | Rating Details | |
2024-08-02 02:53:49 -0500 | Rating Details | |
2024-08-02 02:30:00 -0500 | Rating Details | |
2024-08-02 01:17:06 -0500 | Rating Details | |
2024-08-02 00:59:48 -0500 | Rating Details | |
2024-08-01 22:12:07 -0500 | Rating Details | |
2024-08-01 20:43:50 -0500 | Rating Details | |
2024-08-01 20:21:59 -0500 | Rating Details | |
2024-08-01 18:27:59 -0500 | Rating Details | |
2024-08-01 18:25:55 -0500 | Rating Details | |
2024-08-01 18:07:17 -0500 | Rating Details | |
2024-08-01 17:52:22 -0500 | Rating Details | |
2024-08-01 17:18:35 -0500 | Rating Details | |
2024-08-01 16:28:40 -0500 | Rating Details | |
2024-08-01 16:25:36 -0500 | Rating Details | |
2024-08-01 16:21:44 -0500 | Rating Details | |
2024-08-01 16:18:07 -0500 | Rating Details | |
2024-08-01 16:11:55 -0500 | Rating Details | |
2024-08-01 15:55:37 -0500 | Rating Details | |
2024-08-01 15:48:15 -0500 | Rating Details | |
2024-08-01 15:41:58 -0500 | Rating Details | |
2024-08-01 15:34:45 -0500 | Rating Details | |
2024-08-01 15:26:08 -0500 | Rating Details | |
2024-08-01 15:23:35 -0500 | Rating Details | |
2024-08-01 15:22:44 -0500 | Rating Details | |
2024-08-01 15:22:05 -0500 | Rating Details | |
2024-08-01 15:20:39 -0500 | Rating Details | |
2024-08-01 15:10:37 -0500 | Rating Details | |
2024-08-01 15:09:02 -0500 | Rating Details | |
2024-08-01 15:06:00 -0500 | Rating Details | |
2024-08-01 14:55:55 -0500 | Rating Details | |
2024-08-01 14:50:06 -0500 | Rating Details | |
2024-08-01 14:47:00 -0500 | Rating Details | |
2024-08-01 14:42:38 -0500 | Rating Details | |
2024-08-01 14:42:28 -0500 | Rating Details | |
2024-08-01 14:40:28 -0500 | Rating Details | |
2024-08-01 14:23:51 -0500 | Rating Details | |
2024-08-01 14:09:30 -0500 | Rating Details | |
2024-08-01 14:06:30 -0500 | Rating Details | |
2024-08-01 14:03:59 -0500 | Rating Details | |
2024-08-01 14:01:40 -0500 | Rating Details | |
2024-08-01 13:59:17 -0500 | Rating Details | |
2024-08-01 13:44:26 -0500 | Rating Details | |
2024-08-01 13:39:24 -0500 | Rating Details | |
2024-08-01 13:32:02 -0500 | Rating Details | |
2024-08-01 13:31:41 -0500 | Rating Details | |
2024-08-01 13:28:10 -0500 | Rating Details | |
2024-08-01 13:28:06 -0500 | Rating Details | |
2024-08-01 13:26:33 -0500 | Rating Details | |
2024-08-01 13:18:44 -0500 | Rating Details | |
2024-08-01 13:15:31 -0500 | Rating Details | |
2024-08-01 13:09:21 -0500 | Rating Details | |
2024-08-01 13:00:13 -0500 | Rating Details | |
2024-08-01 12:54:36 -0500 | Rating Details | |
2024-08-01 12:54:08 -0500 | Rating Details | |
2024-08-01 12:50:50 -0500 | Rating Details | |
2024-08-01 12:49:11 -0500 | Rating Details | |
2024-08-01 12:47:44 -0500 | Rating Details | |
2024-08-01 12:46:53 -0500 | Rating Details | |
2024-08-01 12:39:50 -0500 | Rating Details | |
2024-08-01 12:39:38 -0500 | Rating Details | |
2024-08-01 12:35:13 -0500 | Rating Details | |
2024-08-01 12:30:12 -0500 | Rating Details | |
2024-08-01 12:20:04 -0500 | Rating Details | |
2024-08-01 12:08:14 -0500 | Rating Details | |
2024-08-01 12:06:42 -0500 | Rating Details | |
2024-08-01 12:06:08 -0500 | Rating Details | |
2024-08-01 12:02:27 -0500 | Rating Details | |
2024-08-01 12:02:22 -0500 | Rating Details | |
2024-08-01 11:58:03 -0500 | Rating Details | |
2024-08-01 11:57:25 -0500 | Rating Details | |
2024-08-01 11:54:32 -0500 | Rating Details | |
2024-08-01 11:54:13 -0500 | Rating Details | |
2024-08-01 11:53:58 -0500 | Rating Details | |
2024-08-01 11:53:27 -0500 | Rating Details | |
2024-08-01 11:53:20 -0500 | Rating Details | |
2024-08-01 11:53:13 -0500 | Rating Details | |
2024-08-01 11:53:12 -0500 | Rating Details | |
2024-08-01 11:53:11 -0500 | Rating Details | |
2024-08-01 11:52:09 -0500 | Rating Details | |
2024-08-01 11:51:19 -0500 | Rating Details | |
2024-08-01 11:49:24 -0500 | Rating Details | |
2024-08-01 11:48:56 -0500 | Rating Details | |
2024-08-01 11:48:51 -0500 | Rating Details | |
2024-08-01 11:48:03 -0500 | Rating Details | |
2024-08-01 11:47:33 -0500 | Rating Details | |
2024-08-01 11:46:56 -0500 | Rating Details | |
2024-08-01 11:44:19 -0500 | Rating Details | |
2024-08-01 11:42:56 -0500 | Rating Details | |
2024-08-01 11:41:17 -0500 | Rating Details | |
2024-08-01 11:40:25 -0500 | Rating Details | |
2024-08-01 11:39:19 -0500 | Rating Details | |
2024-08-01 11:37:15 -0500 | Rating Details | |
2024-08-01 11:34:51 -0500 | Rating Details | |
2024-08-01 11:31:23 -0500 | Rating Details | |
2024-08-01 11:28:06 -0500 | Rating Details | |
2024-08-01 11:24:37 -0500 | Rating Details | |
2024-08-01 11:22:59 -0500 | Rating Details | |
2024-08-01 11:20:03 -0500 | Rating Details | |
2024-08-01 11:17:50 -0500 | Rating Details | |
2024-08-01 11:16:11 -0500 | Rating Details | |
2024-08-01 11:13:30 -0500 | Rating Details | |
2024-08-01 11:12:41 -0500 | Rating Details | |
2024-08-01 11:12:24 -0500 | Rating Details | |
2024-08-01 11:09:11 -0500 | Rating Details | |
2024-08-01 11:07:54 -0500 | Rating Details | |
2024-08-01 11:07:12 -0500 | Rating Details | |
2024-08-01 11:05:52 -0500 | Rating Details | |
2024-08-01 11:04:17 -0500 | Rating Details | |
2024-08-01 11:02:08 -0500 | Rating Details | |
2024-08-01 10:57:58 -0500 | Rating Details | |
2024-08-01 10:55:21 -0500 | Rating Details | |
2024-08-01 10:53:12 -0500 | Rating Details | |
2024-08-01 10:52:22 -0500 | Rating Details | |
2024-08-01 10:51:48 -0500 | Rating Details | |
2024-08-01 10:50:31 -0500 | Rating Details | |
2024-08-04 01:50:23 -0500 | Rating Details | |
2024-08-03 05:46:04 -0500 | Rating Details | |
2024-08-02 19:58:18 -0500 | Rating Details | |
2024-08-02 11:03:44 -0500 | Rating Details | |
2024-08-02 10:11:42 -0500 | Rating Details | |
2024-08-02 00:48:10 -0500 | Rating Details | |
2024-08-01 23:41:02 -0500 | Rating Details | |
2024-08-01 19:16:24 -0500 | Rating Details |